Trial Outcomes & Findings for Benefits of Microcor in Ambulatory Decompensated Heart Failure (NCT NCT04096040)
NCT ID: NCT04096040
Last Updated: 2025-01-08
Results Overview
Each time a subject's thoracic fluid index (TFI) exceeded a threshold for 3 consecutive days, a data update report was generated by the uCor management system. The site then confirmed its receipt of the data update by completing a case report form. At least 1 of these case report forms was completed for 56 subjects.
COMPLETED
NA
265 participants
90 days
2025-01-08
Participant Flow
Participant milestones
| Measure |
uCor Wearers
Subjects wearing the uCor device
|
|---|---|
|
Overall Study
STARTED
|
265
|
|
Overall Study
COMPLETED
|
249
|
|
Overall Study
NOT COMPLETED
|
16
|
Reasons for withdrawal
| Measure |
uCor Wearers
Subjects wearing the uCor device
|
|---|---|
|
Overall Study
Protocol Violation
|
12
|
|
Overall Study
Non-compliant site
|
4
|
Baseline Characteristics
Benefits of Microcor in Ambulatory Decompensated Heart Failure
Baseline characteristics by cohort
| Measure |
uCor Wearers
n=249 Participants
Subjects wearing the uCor device
|
|---|---|
|
Age, Continuous
|
68.6 years
STANDARD_DEVIATION 13.1 • n=99 Participants
|
|
Sex: Female, Male
Female
|
105 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
144 Participants
n=99 Participants
|
|
Race/Ethnicity, Customized
American Indian or Alaskan Native
|
1 participants
n=99 Participants
|
|
Race/Ethnicity, Customized
Asian
|
3 participants
n=99 Participants
|
|
Race/Ethnicity, Customized
Caucasian
|
135 participants
n=99 Participants
|
|
Race/Ethnicity, Customized
Black or African American
|
63 participants
n=99 Participants
|
|
Race/Ethnicity, Customized
Other
|
5 participants
n=99 Participants
|
|
Race/Ethnicity, Customized
Don't Know/ No Response
|
0 participants
n=99 Participants
|
|
Race/Ethnicity, Customized
Hispanic/ Latino
|
43 participants
n=99 Participants
|
|
Weight
|
205.2 pounds
STANDARD_DEVIATION 63.4 • n=99 Participants
|
|
Height
|
66.6 inches
STANDARD_DEVIATION 4.1 • n=99 Participants
|
|
Blood Pressure (Systolic)
|
126.2 mmHg
STANDARD_DEVIATION 20 • n=99 Participants
|
|
Blood Pressure (Diastolic)
|
72.2 mmHg
STANDARD_DEVIATION 12.1 • n=99 Participants
|
|
Heart Rate (per min)
|
77.1 beats per minute
STANDARD_DEVIATION 13.2 • n=99 Participants
|
|
Respiratory Rate (per min)
|
18 breaths per minute
STANDARD_DEVIATION 5.7 • n=99 Participants
|
|
Time Since Heart Failure Diagnosis
|
4.7 years
STANDARD_DEVIATION 5.8 • n=99 Participants
|
|
Ejection Fraction (Min)
|
41.3 percent of ejection fraction
STANDARD_DEVIATION 15.6 • n=99 Participants
|
|
Ejection Fraction (Max)
|
44.9 percent of ejection fraction
STANDARD_DEVIATION 15.7 • n=99 Participants
|
|
New York Heart Association(NYHA) Class
Class I
|
7 Participants
n=99 Participants
|
|
New York Heart Association(NYHA) Class
Class II
|
102 Participants
n=99 Participants
|
|
New York Heart Association(NYHA) Class
Class III
|
84 Participants
n=99 Participants
|
|
New York Heart Association(NYHA) Class
Class IV
|
2 Participants
n=99 Participants
|
|
New York Heart Association(NYHA) Class
Not Documented
|
54 Participants
n=99 Participants
|
|
Heart Failure Etiology
Ischemic
|
102 Participants
n=99 Participants
|
|
Heart Failure Etiology
Non-ischemic
|
130 Participants
n=99 Participants
|
|
Heart Failure Etiology
Mixed
|
13 Participants
n=99 Participants
|
|
Heart Failure Etiology
N/A or Unknown
|
4 Participants
n=99 Participants
|
|
Educational Level
Less than High School
|
57 Participants
n=99 Participants
|
|
Educational Level
High School
|
132 Participants
n=99 Participants
|
|
Educational Level
Bachelors or Associates
|
37 Participants
n=99 Participants
|
|
Educational Level
Graduate or Professional
|
13 Participants
n=99 Participants
|
|
Educational Level
N/A or Unknown
|
10 Participants
n=99 Participants
|
|
Employment Status
Employed
|
32 Participants
n=99 Participants
|
|
Employment Status
Student
|
0 Participants
n=99 Participants
|
|
Employment Status
Homemaker
|
2 Participants
n=99 Participants
|
|
Employment Status
Unemployed
|
63 Participants
n=99 Participants
|
|
Employment Status
Retired
|
152 Participants
n=99 Participants
|
|
Cardiac Device History
History of Implantable Cardioverter Defibrillator(ICD) · Yes
|
49 Participants
n=99 Participants
|
|
Cardiac Device History
History of Implantable Cardioverter Defibrillator(ICD) · No
|
200 Participants
n=99 Participants
|
|
Cardiac Device History
History of Implantable Cardioverter Defibrillator(ICD) · N/A or Unknown
|
0 Participants
n=99 Participants
|
|
Cardiac Device History
ICD Active at Enrollment · Yes
|
49 Participants
n=99 Participants
|
|
Cardiac Device History
ICD Active at Enrollment · No
|
0 Participants
n=99 Participants
|
|
Cardiac Device History
ICD Active at Enrollment · N/A or Unknown
|
200 Participants
n=99 Participants
|
|
Cardiac Device History
History of Pacemaker · Yes
|
45 Participants
n=99 Participants
|
|
Cardiac Device History
History of Pacemaker · No
|
204 Participants
n=99 Participants
|
|
Cardiac Device History
History of Pacemaker · N/A or Unknown
|
0 Participants
n=99 Participants
|
|
Cardiac Device History
Pacemaker Active at Enrollment · Yes
|
43 Participants
n=99 Participants
|
|
Cardiac Device History
Pacemaker Active at Enrollment · No
|
2 Participants
n=99 Participants
|
|
Cardiac Device History
Pacemaker Active at Enrollment · N/A or Unknown
|
204 Participants
n=99 Participants
|
|
History of Remote Heart Failure(HF) Monitor
Yes
|
2 participants
n=99 Participants
|
|
History of Remote Heart Failure(HF) Monitor
No
|
247 participants
n=99 Participants
|
|
History of Hypertension
Yes
|
233 Participants
n=99 Participants
|
|
History of Hypertension
No
|
14 Participants
n=99 Participants
|
|
History of Hypertension
Uknown
|
2 Participants
n=99 Participants
|
|
History of Diabetes
Yes
|
141 Participants
n=99 Participants
|
|
History of Diabetes
No
|
107 Participants
n=99 Participants
|
|
History of Diabetes
Unknown
|
1 Participants
n=99 Participants
|
|
History of Chronic Obstructive Pulmonary Disease (COPD)
Yes
|
86 Participants
n=99 Participants
|
|
History of Chronic Obstructive Pulmonary Disease (COPD)
No
|
157 Participants
n=99 Participants
|
|
History of Chronic Obstructive Pulmonary Disease (COPD)
Unknown
|
6 Participants
n=99 Participants
|
|
History of Transient Ischemic Attack (TIA)
Yes
|
33 Participants
n=99 Participants
|
|
History of Transient Ischemic Attack (TIA)
No
|
215 Participants
n=99 Participants
|
|
History of Transient Ischemic Attack (TIA)
Unknown
|
1 Participants
n=99 Participants
|
|
History of Chronic Kidney Disease (CKD)
Yes
|
118 Participants
n=99 Participants
|
|
History of Chronic Kidney Disease (CKD)
No
|
128 Participants
n=99 Participants
|
|
History of Chronic Kidney Disease (CKD)
Unknown
|
3 Participants
n=99 Participants
|
|
History of Angina
Yes
|
78 Participants
n=99 Participants
|
|
History of Angina
No
|
159 Participants
n=99 Participants
|
|
History of Angina
Unknown
|
12 Participants
n=99 Participants
|
|
History of Syncope
Yes
|
33 Participants
n=99 Participants
|
|
History of Syncope
No
|
208 Participants
n=99 Participants
|
|
History of Syncope
Unknown
|
8 Participants
n=99 Participants
|
|
History of Sudden Cardiac Arrest (SCA)
Yes
|
9 Participants
n=99 Participants
|
|
History of Sudden Cardiac Arrest (SCA)
No
|
237 Participants
n=99 Participants
|
|
History of Sudden Cardiac Arrest (SCA)
Unknown
|
3 Participants
n=99 Participants
|
|
History of Arrhythmia
Yes
|
153 Participants
n=99 Participants
|
|
History of Arrhythmia
No
|
88 Participants
n=99 Participants
|
|
History of Arrhythmia
Unknown
|
8 Participants
n=99 Participants
|
|
History of Myocardial Infarction (MI)
Yes
|
83 Participants
n=99 Participants
|
|
History of Myocardial Infarction (MI)
No
|
157 Participants
n=99 Participants
|
|
History of Myocardial Infarction (MI)
Unknown
|
9 Participants
n=99 Participants
|
|
History of Coronary Artery Bypass Graft (CABG)
Yes
|
48 Participants
n=99 Participants
|
|
History of Coronary Artery Bypass Graft (CABG)
No
|
199 Participants
n=99 Participants
|
|
History of Coronary Artery Bypass Graft (CABG)
Unknown
|
2 Participants
n=99 Participants
|
|
History of Percutaneous Coronary Intervention (PCI)
Yes
|
85 Participants
n=99 Participants
|
|
History of Percutaneous Coronary Intervention (PCI)
No
|
161 Participants
n=99 Participants
|
|
History of Percutaneous Coronary Intervention (PCI)
Unknown
|
3 Participants
n=99 Participants
|
PRIMARY outcome
Timeframe: 90 daysPopulation: data updates per subject
Each time a subject's thoracic fluid index (TFI) exceeded a threshold for 3 consecutive days, a data update report was generated by the uCor management system. The site then confirmed its receipt of the data update by completing a case report form. At least 1 of these case report forms was completed for 56 subjects.
Outcome measures
| Measure |
uCor Wearers
n=415 data updates
Subjects wearing the uCor device
|
uCor Wearers Reporting Severe Symptoms
Subjects wearing the uCor device that reported severe symptoms that were preceded by a valid device measure.
|
uCor Wearers - 1 Year Data
Subjects still active in the study at 1 year post-enrollment.
|
|---|---|---|---|
|
Number of Data Updates Received by the uCor Subject Management System
|
3 data updates per subject
Interval 1.0 to 10.0
|
—
|
—
|
PRIMARY outcome
Timeframe: 90 daysSites reviewed data reports in each of the following contexts: planned weekly phone call, planned office visit, unplanned phone call, unplanned office visit, and data update. Sites reported whether they spent less than 5, 5 to 10, or greater than 10 minutes reviewing each report. At least 1 of these case report forms was completed for 214 subjects.
Outcome measures
| Measure |
uCor Wearers
n=2107 Number of data reports
Subjects wearing the uCor device
|
uCor Wearers Reporting Severe Symptoms
Subjects wearing the uCor device that reported severe symptoms that were preceded by a valid device measure.
|
uCor Wearers - 1 Year Data
Subjects still active in the study at 1 year post-enrollment.
|
|---|---|---|---|
|
Approximate Time Spent Reviewing Data Reports Assessment Across Sites (PO 2: Part 1/2)
0-5 minutes
|
1548 Number of data reports
|
—
|
—
|
|
Approximate Time Spent Reviewing Data Reports Assessment Across Sites (PO 2: Part 1/2)
5-10 minutes
|
427 Number of data reports
|
—
|
—
|
|
Approximate Time Spent Reviewing Data Reports Assessment Across Sites (PO 2: Part 1/2)
>10 minutes
|
132 Number of data reports
|
—
|
—
|
PRIMARY outcome
Timeframe: 90 daysPopulation: Most common amount of time spent reviewing by each site
Sites reviewed data reports in each of the following contexts: planned weekly phone call, planned office visit, unplanned phone call, unplanned office visit, and data update. Sites reported whether they spent less than 5, 5 to 10, or greater than 10 minutes reviewing each report. At least 1 of these case report forms was completed for 214 subjects.
Outcome measures
| Measure |
uCor Wearers
n=44 number of sites
Subjects wearing the uCor device
|
uCor Wearers Reporting Severe Symptoms
Subjects wearing the uCor device that reported severe symptoms that were preceded by a valid device measure.
|
uCor Wearers - 1 Year Data
Subjects still active in the study at 1 year post-enrollment.
|
|---|---|---|---|
|
Approximate Time Spent Reviewing Data Reports Assessment Within Sites (PO 2: Part 2/2)
0-5 minutes
|
34 number of sites
|
—
|
—
|
|
Approximate Time Spent Reviewing Data Reports Assessment Within Sites (PO 2: Part 2/2)
5-10 minutes
|
9 number of sites
|
—
|
—
|
|
Approximate Time Spent Reviewing Data Reports Assessment Within Sites (PO 2: Part 2/2)
>10 minutes
|
1 number of sites
|
—
|
—
|
PRIMARY outcome
Timeframe: 90 daysPopulation: Number of medication changes or lifestyle modifications per subject based on μCor data and symptoms
Sites reviewed data reports in each of the following contexts: planned weekly phone call, planned office visit, unplanned phone call, unplanned office visit, and data update. In each context, the subject was asked whether their symptoms changed. If yes, the site reported in a case report form whether it took action to treat the subject in the form of a medication change or lifestyle modification. At least one of these case report forms (CRFs) was completed for 214 subjects
Outcome measures
| Measure |
uCor Wearers
n=159 number of MC/LS changes
Subjects wearing the uCor device
|
uCor Wearers Reporting Severe Symptoms
Subjects wearing the uCor device that reported severe symptoms that were preceded by a valid device measure.
|
uCor Wearers - 1 Year Data
Subjects still active in the study at 1 year post-enrollment.
|
|---|---|---|---|
|
The Number of Medication Changes(MC) and Lifestyle Modifications(LS) Recommended to the Subject Based on Evaluating μCor Data and Symptoms (PO 3: Part 1/3)
Number of medication changes based on μCor data and symptoms
|
114 number of MC/LS changes
|
—
|
—
|
|
The Number of Medication Changes(MC) and Lifestyle Modifications(LS) Recommended to the Subject Based on Evaluating μCor Data and Symptoms (PO 3: Part 1/3)
Number of lifestyle modifications based on μCor data and symptoms
|
45 number of MC/LS changes
|
—
|
—
|
PRIMARY outcome
Timeframe: 90 daysPopulation: Number of subjects with medication changes based on μCor data and symptoms
Sites reviewed data reports in each of the following contexts: planned weekly phone call, planned office visit, unplanned phone call, unplanned office visit, and data update. In each context, the subject was asked whether their symptoms changed. If yes, the site reported in a case report form whether it took action to treat the subject in the form of a medication change or lifestyle modification. At least one of these case report forms (CRFs) was completed for 214 subjects.
Outcome measures
| Measure |
uCor Wearers
n=68 Participants
Subjects wearing the uCor device
|
uCor Wearers Reporting Severe Symptoms
Subjects wearing the uCor device that reported severe symptoms that were preceded by a valid device measure.
|
uCor Wearers - 1 Year Data
Subjects still active in the study at 1 year post-enrollment.
|
|---|---|---|---|
|
The Number of Medication Changes(MC) and Lifestyle Modifications(LS) Recommended to the Subject Based on Evaluating μCor Data and Symptoms (PO 3: Part 2/3)
Number of subjects with 1 medication change(s) based on μCor data and symptoms
|
38 Participants
|
—
|
—
|
|
The Number of Medication Changes(MC) and Lifestyle Modifications(LS) Recommended to the Subject Based on Evaluating μCor Data and Symptoms (PO 3: Part 2/3)
Number of subjects with 2 medication change(s) based on μCor data and symptoms
|
19 Participants
|
—
|
—
|
|
The Number of Medication Changes(MC) and Lifestyle Modifications(LS) Recommended to the Subject Based on Evaluating μCor Data and Symptoms (PO 3: Part 2/3)
Number of subjects with 3+ medication change(s) based on μCor data and symptoms
|
11 Participants
|
—
|
—
|
PRIMARY outcome
Timeframe: 90 daysPopulation: Number of subjects with lifestyle modifications based on μCor data and symptoms
Sites reviewed data reports in each of the following contexts: planned weekly phone call, planned office visit, unplanned phone call, unplanned office visit, and data update. In each context, the subject was asked whether their symptoms changed. If yes, the site reported in a case report form whether it took action to treat the subject in the form of a medication change or lifestyle modification. At least one of these case report forms (CRFs) was completed for 214 subjects
Outcome measures
| Measure |
uCor Wearers
n=17 Participants
Subjects wearing the uCor device
|
uCor Wearers Reporting Severe Symptoms
Subjects wearing the uCor device that reported severe symptoms that were preceded by a valid device measure.
|
uCor Wearers - 1 Year Data
Subjects still active in the study at 1 year post-enrollment.
|
|---|---|---|---|
|
The Number of Medication Changes(MC) and Lifestyle Modifications(LS) Recommended to the Subject Based on Evaluating μCor Data and Symptoms (PO 3: Part 3/3)
Number of subjects with 1 lifestyle modification(s) based on μCor data and symptoms
|
8 Participants
|
—
|
—
|
|
The Number of Medication Changes(MC) and Lifestyle Modifications(LS) Recommended to the Subject Based on Evaluating μCor Data and Symptoms (PO 3: Part 3/3)
Number of subjects with 2 lifestyle modification(s) based on μCor data and symptoms
|
2 Participants
|
—
|
—
|
|
The Number of Medication Changes(MC) and Lifestyle Modifications(LS) Recommended to the Subject Based on Evaluating μCor Data and Symptoms (PO 3: Part 3/3)
Number of subjects with 3 lifestyle modification(s) based on μCor data and symptoms
|
3 Participants
|
—
|
—
|
|
The Number of Medication Changes(MC) and Lifestyle Modifications(LS) Recommended to the Subject Based on Evaluating μCor Data and Symptoms (PO 3: Part 3/3)
Number of subjects with 4+ lifestyle modification(s) based on μCor data and symptoms
|
4 Participants
|
—
|
—
|
PRIMARY outcome
Timeframe: 90 daysPopulation: Subjects with Medication Changes (MC) based on incidental findings
During weekly planned phone calls, planned office visits, and unplanned office visits, sites asked subjects whether they underwent any changes to their heart failure and/or cardiac medications since the last phone call and reported the result in a case report form. At least 1 of these case report forms was completed for 241 subjects.
Outcome measures
| Measure |
uCor Wearers
n=139 Participants
Subjects wearing the uCor device
|
uCor Wearers Reporting Severe Symptoms
Subjects wearing the uCor device that reported severe symptoms that were preceded by a valid device measure.
|
uCor Wearers - 1 Year Data
Subjects still active in the study at 1 year post-enrollment.
|
|---|---|---|---|
|
The Number of Medication Changes Based on Subject Incidental Findings
Number of subjects with 2 medication change(s) based on incidental findings
|
35 Participants
|
—
|
—
|
|
The Number of Medication Changes Based on Subject Incidental Findings
Number of subjects with 3 medication change(s) based on incidental findings
|
20 Participants
|
—
|
—
|
|
The Number of Medication Changes Based on Subject Incidental Findings
Number of subjects with 1 medication change(s) based on incidental findings
|
58 Participants
|
—
|
—
|
|
The Number of Medication Changes Based on Subject Incidental Findings
Number of subjects with 4 medication change(s) based on incidental findings
|
10 Participants
|
—
|
—
|
|
The Number of Medication Changes Based on Subject Incidental Findings
Number of subjects with 5 medication change(s) based on incidental findings
|
8 Participants
|
—
|
—
|
|
The Number of Medication Changes Based on Subject Incidental Findings
Number of subjects with 6+ medication change(s) based on incidental findings
|
8 Participants
|
—
|
—
|
PRIMARY outcome
Timeframe: 90 daysPopulation: MC/LS events preceded by a high uCor measurement within -13 to 0 days
482 medication changes or lifestyle (MC/LS) modifications occurred within the first 90 days of the study. To include only medication changes preceded and followed by sufficient µCor data to determine a threshold crossing, medication changes within the first 2 weeks of the study or the final 3 weeks of device wear were discarded. This resulted in in 262 analyzable changes. Changes occurring within 1 week of another change were grouped together. This resulted in 192 change events. Time windows were defined as 0-13 days before the first change in a change event vs. 8-21 days after the last change in a change event. A high μCor measurement was defined as the receipt of a data update by the site. A low μCor measurement was defined as the absence of a data update received by the site.
Outcome measures
| Measure |
uCor Wearers
n=40 MC/LS change events
Subjects wearing the uCor device
|
uCor Wearers Reporting Severe Symptoms
Subjects wearing the uCor device that reported severe symptoms that were preceded by a valid device measure.
|
uCor Wearers - 1 Year Data
Subjects still active in the study at 1 year post-enrollment.
|
|---|---|---|---|
|
Number of Times High μCor Measurements Were Reduced Below Threshold Levels After Medication Was Titrated or Lifestyle Modifications Were Recommended
MC/LS preceded by a high μCor meas. w/i -13 to 0 days,followed by a high uCor meas. w/i +8 to+21days
|
19 MC/LS change events
|
—
|
—
|
|
Number of Times High μCor Measurements Were Reduced Below Threshold Levels After Medication Was Titrated or Lifestyle Modifications Were Recommended
MC/LS preceded by a high μCor meas. w/i -13 to 0 days,followed by a low uCor meas. w/i +8 to+21 days
|
21 MC/LS change events
|
—
|
—
|
SECONDARY outcome
Timeframe: 90 daysPopulation: The median was calculated for the 7 days prior to the 1st heart failure (HF) event; the median was calculated for the final 7 days of device wear. ROC analysis was performed. Data are presented assuming that the device reading in subjects without events is less than that of subjects with events. Unit of measure: probability that a randomly chosen subject with severe symptoms has a greater device value than a randomly chosen subject with mild symptoms.
Definitions: Daytime: 7:00 AM - 12:00 AM Nighttime: 12:00 AM - 7:00 AM For each day on which the subject wore the device, the following values were calculated: Daytime activity: The proportion of minutes while wearing the device that the subject spent active (unitless). Nighttime heart rate: The median heart rate while wearing the device during the night (beats/min) Thoracic fluid index: The median proportion of ratio of radiofrequency-measured lung fluid readings compared to the subject's baseline (unitless). Nighttime posture: The median pitch angle while wearing the device during the night (degrees, where 0 is the horizontal). Nighttime respiration: The median respiration rate while wearing the device during the night (breaths/min) HF event: a hospitalization, emergency room visit, observation unit visit, unplanned clinic visit, or death primarily due to heart failure.
Outcome measures
| Measure |
uCor Wearers
n=249 Participants
Subjects wearing the uCor device
|
uCor Wearers Reporting Severe Symptoms
Subjects wearing the uCor device that reported severe symptoms that were preceded by a valid device measure.
|
uCor Wearers - 1 Year Data
Subjects still active in the study at 1 year post-enrollment.
|
|---|---|---|---|
|
Strength of Association Between μCor Measurements and Clinically Related Heart Failure Events.
Daytime Activity
|
0.45 probability
Interval 0.34 to 0.57
|
—
|
—
|
|
Strength of Association Between μCor Measurements and Clinically Related Heart Failure Events.
Nighttime Heart Rate
|
0.57 probability
Interval 0.45 to 0.68
|
—
|
—
|
|
Strength of Association Between μCor Measurements and Clinically Related Heart Failure Events.
Nighttime Respiration Rate
|
0.52 probability
Interval 0.39 to 0.66
|
—
|
—
|
|
Strength of Association Between μCor Measurements and Clinically Related Heart Failure Events.
Nighttime Posture
|
0.57 probability
Interval 0.46 to 0.68
|
—
|
—
|
|
Strength of Association Between μCor Measurements and Clinically Related Heart Failure Events.
Thoracic Fluid Index
|
0.61 probability
Interval 0.51 to 0.71
|
—
|
—
|
SECONDARY outcome
Timeframe: 90 daysPopulation: The median of the daily medians for each device measure was calculated for the 7 days preceding each office visit. To assess whether reports of severe \[frequent or continuous\] symptoms were associated with greater device measures than reports of mild symptoms \[none or seldom\], ROC analysis was performed. Unit of measure: probability that a randomly chosen subject with severe symptoms has a greater device value than a randomly chosen subject with mild symptoms.
During office visits at months 1, 2, and 3, subjects reported their degrees of dyspnea, orthopnea, and fatigue on the following scale: \[none, seldom, frequent, continuous\]. Each day that the subject wore the device, a daily median was calculated for the following measures: \[thoracic fluid index, nighttime heart rate, nighttime respiration rate\]. Nighttime was defined as 12:00 AM - 7:00 AM.
Outcome measures
| Measure |
uCor Wearers
n=249 Participants
Subjects wearing the uCor device
|
uCor Wearers Reporting Severe Symptoms
Subjects wearing the uCor device that reported severe symptoms that were preceded by a valid device measure.
|
uCor Wearers - 1 Year Data
Subjects still active in the study at 1 year post-enrollment.
|
|---|---|---|---|
|
Strength of Association Between μCor Measurements and Subject Reported Symptoms
Dyspnea and Thoracic Fluid Index (TFI)
|
0.54 probability
Interval 0.47 to 0.61
|
—
|
—
|
|
Strength of Association Between μCor Measurements and Subject Reported Symptoms
Dyspnea and Nighttime Heart Rate
|
0.49 probability
Interval 0.42 to 0.56
|
—
|
—
|
|
Strength of Association Between μCor Measurements and Subject Reported Symptoms
Dyspnea and Nighttime Respiration Rate
|
0.52 probability
Interval 0.45 to 0.59
|
—
|
—
|
|
Strength of Association Between μCor Measurements and Subject Reported Symptoms
Orthopnea and Thoracic Fluid Index (TFI)
|
0.52 probability
Interval 0.44 to 0.61
|
—
|
—
|
|
Strength of Association Between μCor Measurements and Subject Reported Symptoms
Orthopnea and Nighttime Heart Rate
|
0.53 probability
Interval 0.44 to 0.62
|
—
|
—
|
|
Strength of Association Between μCor Measurements and Subject Reported Symptoms
Orthopnea and Nighttime Respiration Rate
|
0.60 probability
Interval 0.52 to 0.69
|
—
|
—
|
|
Strength of Association Between μCor Measurements and Subject Reported Symptoms
Fatigue and Thoracic Fluid Index (TFI)
|
0.57 probability
Interval 0.5 to 0.63
|
—
|
—
|
|
Strength of Association Between μCor Measurements and Subject Reported Symptoms
Fatigue and Nighttime Heart Rate
|
0.51 probability
Interval 0.45 to 0.58
|
—
|
—
|
|
Strength of Association Between μCor Measurements and Subject Reported Symptoms
Fatigue and Nighttime Respiration Rate
|
0.54 probability
Interval 0.48 to 0.61
|
—
|
—
|
SECONDARY outcome
Timeframe: 90 daysPopulation: Each of the 249 participants in the study could contribute data to either Arm/Group depending on the severity of their symptoms across the 3-month study duration.
During office visits at months 1, 2, and 3, subjects reported their degrees of dyspnea, orthopnea, and fatigue on the following scale: \[none, seldom, frequent, continuous\].
Outcome measures
| Measure |
uCor Wearers
n=249 Participants
Subjects wearing the uCor device
|
uCor Wearers Reporting Severe Symptoms
n=249 Participants
Subjects wearing the uCor device that reported severe symptoms that were preceded by a valid device measure.
|
uCor Wearers - 1 Year Data
Subjects still active in the study at 1 year post-enrollment.
|
|---|---|---|---|
|
Correlations Between uCor Measurements and Patient Reported Symptoms: Mild/Severe Symptoms
Dyspnea - Thoracic Fluid Index (TFI)
|
255 Symptom reports
|
100 Symptom reports
|
—
|
|
Correlations Between uCor Measurements and Patient Reported Symptoms: Mild/Severe Symptoms
Orthopnea - Thoracic Fluid Index (TFI)
|
299 Symptom reports
|
56 Symptom reports
|
—
|
|
Correlations Between uCor Measurements and Patient Reported Symptoms: Mild/Severe Symptoms
Dyspnea - Nighttime Heart Rate (NHR)
|
253 Symptom reports
|
99 Symptom reports
|
—
|
|
Correlations Between uCor Measurements and Patient Reported Symptoms: Mild/Severe Symptoms
Dyspnea - Nighttime Respiration Rate (NRR)
|
254 Symptom reports
|
99 Symptom reports
|
—
|
|
Correlations Between uCor Measurements and Patient Reported Symptoms: Mild/Severe Symptoms
Orthopnea - Nighttime Heart Rate (NHR)
|
294 Symptom reports
|
57 Symptom reports
|
—
|
|
Correlations Between uCor Measurements and Patient Reported Symptoms: Mild/Severe Symptoms
Orthopnea - Nighttime Respiration Rate (NRR)
|
296 Symptom reports
|
56 Symptom reports
|
—
|
|
Correlations Between uCor Measurements and Patient Reported Symptoms: Mild/Severe Symptoms
Fatigue - Thoracic Fluid Index (TFI)
|
232 Symptom reports
|
123 Symptom reports
|
—
|
|
Correlations Between uCor Measurements and Patient Reported Symptoms: Mild/Severe Symptoms
Fatigue - Nighttime Heart Rate (NHR)
|
227 Symptom reports
|
124 Symptom reports
|
—
|
|
Correlations Between uCor Measurements and Patient Reported Symptoms: Mild/Severe Symptoms
Fatigue - Nighttime Respiration Rate (NRR)
|
230 Symptom reports
|
122 Symptom reports
|
—
|
SECONDARY outcome
Timeframe: 90 daysPopulation: Subjects who had hospital readmission, physician visit, and/or outpatient clinic visit during the study period
For each weekly phone call and monthly office visit, each subject reported whether they experienced a hospitalization or emergency room visit since their last call/visit. An adjudication committee of physicians determined whether each event was due to HF or not.
Outcome measures
| Measure |
uCor Wearers
n=39 Participants
Subjects wearing the uCor device
|
uCor Wearers Reporting Severe Symptoms
Subjects wearing the uCor device that reported severe symptoms that were preceded by a valid device measure.
|
uCor Wearers - 1 Year Data
Subjects still active in the study at 1 year post-enrollment.
|
|---|---|---|---|
|
Hospital Readmission Rate, Physician Visit Rate, and Outpatient Clinic Visit Rate During the Study Period
Subjects with Hospital Readmission for Heart Failure between enrollment and Day 90
|
32 Participants
|
—
|
—
|
|
Hospital Readmission Rate, Physician Visit Rate, and Outpatient Clinic Visit Rate During the Study Period
Subjects with an ER visit for Heart Failure between enrollment and Day 90
|
7 Participants
|
—
|
—
|
SECONDARY outcome
Timeframe: 6 months and 1 yearPopulation: Descriptive statistics around mortality rate, cause of death, quality of life (QoL), and health care utilization among patients six months and one year after enrollment into the study.
On each subject's final date of study participation, their survival status was recorded.
Outcome measures
| Measure |
uCor Wearers
n=249 Participants
Subjects wearing the uCor device
|
uCor Wearers Reporting Severe Symptoms
n=249 Participants
Subjects wearing the uCor device that reported severe symptoms that were preceded by a valid device measure.
|
uCor Wearers - 1 Year Data
Subjects still active in the study at 1 year post-enrollment.
|
|---|---|---|---|
|
Mortality Rate, Heart Failure Related Events, Quality of Life (QoL) and Healthcare Utilization Data at 6 Months and One Year Post Enrollment: Mortality Data
Number of Subjects reported as deceased
|
20 Participants
|
37 Participants
|
—
|
|
Mortality Rate, Heart Failure Related Events, Quality of Life (QoL) and Healthcare Utilization Data at 6 Months and One Year Post Enrollment: Mortality Data
Number of Subjects not reported as deceased
|
229 Participants
|
212 Participants
|
—
|
SECONDARY outcome
Timeframe: 6 months and 1 yearPopulation: Descriptive statistics around mortality rate, cause of death, quality of life (QoL), and health care utilization among patients six months and one year after enrollment into the study.
On each subject's final date of study participation, in the case of death, the cause of death was recorded.
Outcome measures
| Measure |
uCor Wearers
n=37 Deaths
Subjects wearing the uCor device
|
uCor Wearers Reporting Severe Symptoms
Subjects wearing the uCor device that reported severe symptoms that were preceded by a valid device measure.
|
uCor Wearers - 1 Year Data
Subjects still active in the study at 1 year post-enrollment.
|
|---|---|---|---|
|
Mortality Rate, Cause of Death, Quality of Life (QoL) and Healthcare Utilization Data at 6 Months and One Year Post Enrollment: Cause of Death
Cardiac-Sudden Cardiac Arrest
|
2 Deaths
|
—
|
—
|
|
Mortality Rate, Cause of Death, Quality of Life (QoL) and Healthcare Utilization Data at 6 Months and One Year Post Enrollment: Cause of Death
Cardiac-Heart Failure
|
10 Deaths
|
—
|
—
|
|
Mortality Rate, Cause of Death, Quality of Life (QoL) and Healthcare Utilization Data at 6 Months and One Year Post Enrollment: Cause of Death
Cardiac-Hypotension
|
1 Deaths
|
—
|
—
|
|
Mortality Rate, Cause of Death, Quality of Life (QoL) and Healthcare Utilization Data at 6 Months and One Year Post Enrollment: Cause of Death
Cardiac-Heart Disease
|
1 Deaths
|
—
|
—
|
|
Mortality Rate, Cause of Death, Quality of Life (QoL) and Healthcare Utilization Data at 6 Months and One Year Post Enrollment: Cause of Death
Non-cardiac
|
12 Deaths
|
—
|
—
|
|
Mortality Rate, Cause of Death, Quality of Life (QoL) and Healthcare Utilization Data at 6 Months and One Year Post Enrollment: Cause of Death
Unknown
|
11 Deaths
|
—
|
—
|
SECONDARY outcome
Timeframe: 6 months and 1 yearPopulation: Descriptive statistics around mortality rate, cause of death, quality of life (QoL), and health care utilization among patients six months and one year after enrollment into the study.
At 0 months, 6 months, and 1 year after enrollment, subjects completed a Kansas City Cardiomyopathy Questionnaire (KCCQ-12). Quality of life is calculated as: KCCQ12-QL = 100\*\[(average of Questions 6 and 7) - 1\]/4 Score is scaled 0-100, where 0 denotes the lowest reportable health status and 100 the highest.
Outcome measures
| Measure |
uCor Wearers
n=249 Participants
Subjects wearing the uCor device
|
uCor Wearers Reporting Severe Symptoms
n=96 Participants
Subjects wearing the uCor device that reported severe symptoms that were preceded by a valid device measure.
|
uCor Wearers - 1 Year Data
n=90 Participants
Subjects still active in the study at 1 year post-enrollment.
|
|---|---|---|---|
|
Mortality Rate, Heart Failure Related Events, Quality of Life (QoL) and Healthcare Utilization Data at 6 Months and One Year Post Enrollment: Quality of Life Data
|
32 score on a scale
Standard Deviation 27.1
|
54.8 score on a scale
Standard Deviation 28.3
|
58.2 score on a scale
Standard Deviation 24.9
|
SECONDARY outcome
Timeframe: 6 months and 1 yearPopulation: All subjects in the study from the timepoint of enrollment until end of study participation.
For each weekly phone call, monthly office visit, 6-month phone call, and 1-year phone call, each subject reported whether they experienced a hospitalization, emergency room visit, or unplanned doctor's office visit since their last call/visit.
Outcome measures
| Measure |
uCor Wearers
n=249 Participants
Subjects wearing the uCor device
|
uCor Wearers Reporting Severe Symptoms
n=249 Participants
Subjects wearing the uCor device that reported severe symptoms that were preceded by a valid device measure.
|
uCor Wearers - 1 Year Data
Subjects still active in the study at 1 year post-enrollment.
|
|---|---|---|---|
|
Mortality Rate, Heart Failure Related Events, Quality of Life (QoL) and Healthcare Utilization Data at 6 Months and One Year Post Enrollment: Healthcare Utilization Data
Subjects with hospitalization for any reason
|
120 participants
|
134 participants
|
—
|
|
Mortality Rate, Heart Failure Related Events, Quality of Life (QoL) and Healthcare Utilization Data at 6 Months and One Year Post Enrollment: Healthcare Utilization Data
Subjects with ER visit for any reason
|
101 participants
|
119 participants
|
—
|
|
Mortality Rate, Heart Failure Related Events, Quality of Life (QoL) and Healthcare Utilization Data at 6 Months and One Year Post Enrollment: Healthcare Utilization Data
Subjects with unplanned doctor's office visit for any reason
|
55 participants
|
62 participants
|
—
|
Adverse Events
Single-Arm, Eligible Subjects
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Single-Arm, Eligible Subjects
n=265 participants at risk
Subjects hospitalized for acute decompensated heart failure and enrolled in the study within 10 days post-hospital discharge.
All subjects require an additional heart failure event within the previous 180 days.
|
|---|---|
|
Skin and subcutaneous tissue disorders
Skin Irritation
|
40.0%
106/265 • Number of events 143 • 1 year + 30 days, per subject
All device related adverse effects will be recorded during the study. All adverse device effects (ADEs) will be classified by the investigator as anticipated or unanticipated. Adverse events will also include any adverse events related to medication changes and medical procedures initiated by μCor data.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place